In some patients, it appears that the development of hyperphosphatemia has rendered previously therapeutic doses of calcitriol ineffective at suppressing PTH (serum phosphorus > 2.6 mmol/L [> 8.0 mg/dL]). This evidence concerns the gene PTH and hyperphosphatemia.